This is the key line: The team of Doherty Institute researchers...

This is the key line: The team of Doherty Institute researchers has, for the first time, mapped the way a patient’s immune system responds to the virus

They aren't talking about any particular drug or company but the work they have done will benefit any company looking to find a vaccine or a cure.

BIT may be involved in this but at this stage there isn't anything for BIT to ANN because the article isn't talking about a specific cure or vaccine (sorry to repeat myself....just want that to sink in).
Oon face value this news isn't good or bad for BIT. Of course we can draw the link between Doherty and BIT which is fine as long as we all remember this isn't speculation.

I have a sizeable holding and am a long termer. Can't afford to top up at these great prices so not down ramping. Just want us to keep to the facts.